U.S. Entertainment Stock News

NYSE:IT
NYSE:ITIT

Gartner (IT) Stock May Sit Below Fair Value Despite Fresh AI Demand News

Gartner stock has had a tough run over the past year, yet current valuation checks suggest the share price may now sit below what its Discounted Cash Flow (DCF) and earnings multiple signals imply for intrinsic value. Over the past 12 months the share price has fallen 51.8%, which puts recent gains into context and raises the question of whether sentiment has moved further than the fundamentals. Recent headlines around Gartner's AI forecasts and its role in shaping spending on AI...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

Is Nexstar Media Group (NXST) Below Fair Value On Its Kansas Debate Telecast News?

Nexstar Media Group (NXST) is drawing attention after announcing that its Kansas stations will air a live, multi market telecast of the Democratic governor candidates' debate on July 31 across TV and digital platforms. See our latest analysis for Nexstar Media Group. The debate announcement comes as Nexstar Media Group’s recent momentum has picked up, with a 7 day share price return of 8.71% and a 30 day share price return of 10.27%, even though the year to date share price return is down...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...
NYSE:IP
NYSE:IPPackaging

International Paper (IP) Stock Looks Undervalued On Fair Value But Richer On Sales

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Tarsus Pharmaceuticals (TARS) Could Be 38% Undervalued Following Cautious Earnings Expectations

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...
NYSE:COF
NYSE:COFConsumer Finance

Synchrony Financial Stock And Two Consumer Lenders Under Pressure From High Rates

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX) Wins FDA Approval For EZPLAZ, Is The Stock Still Below Fair Value?

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Does BioMarin (BMRN) Expanding Into ReNU Syndrome Refine Its Rare Disease Pipeline Strategy?

Earlier this week, n-Lorem Foundation announced an early-stage research collaboration and exclusive global licence agreement with BioMarin Pharmaceutical to develop an investigational antisense oligonucleotide therapy for ReNU syndrome, with preclinical work underway and plans for future clinical studies. A key aspect of the deal is BioMarin’s intention to develop the medicine for broader use across the ReNU syndrome community, aiming to address an estimated 75% of cases and potentially...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Is Capital Clean Energy Carriers (CCEC) Fairly Valued As Q2 Earnings Show Higher Sales But Lower Profit?

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...
NYSE:FBP
NYSE:FBPBanks

Is Stronger Q2 Earnings And Capital Returns Altering The Investment Case For First BanCorp (FBP)?

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...
NYSE:CVS
NYSE:CVSHealthcare

Is CVS Health (CVS) Fully Valued As Earnings Optimism Builds?

Why CVS Health Stock Is Back On Investors’ Radar CVS Health (CVS) has drawn fresh attention ahead of its upcoming quarterly earnings report, as investors weigh upbeat expectations alongside a run of recent business updates and industry recognition. Over the past year, CVS Health stock has outperformed the broader market and delivered a total return of 75.4%. The share price closed at US$105.92 on 29 July 2026, with gains of 2.3% over the past month and 27.2% over the past 3 months. See our...
NYSE:DAL
NYSE:DALAirlines

Is Delta Air Lines (DAL) A Bargain After Raised 2026 Guidance And Q2 Earnings Beat?

Guidance surprise puts Delta Air Lines (DAL) earnings in focus Delta Air Lines (DAL) lifted its full-year 2026 revenue, adjusted operating profit, and earnings guidance after reporting second-quarter results that topped expectations despite higher fuel costs and ongoing network adjustments. See our latest analysis for Delta Air Lines. Delta Air Lines’ 1 day share price return declined 3.49% to US$86.25. However, the 90 day share price return of 26.86% and 1 year total shareholder return of...
NYSE:EFX
NYSE:EFXProfessional Services

Equifax (EFX) Is Up 9.7% After Leveraging Up To Fund Buybacks And Guide Double-Digit Growth – Has The Bull Case Changed?

In late July 2026, Equifax Inc. reported second-quarter results showing higher sales of US$1,700.1 million but lower net income of US$183.9 million year-on-year, issued third-quarter 2026 guidance calling for revenue of US$1.68 billion to US$1.71 billion and EPS of US$2.15 to US$2.25, completed two fixed-income offerings totaling about US$998 million in senior unsecured callable notes, and disclosed completion of a US$1,487.36 million share repurchase program covering 7,113,801 shares. An...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Stock May Be 14% Undervalued Despite Sales Declines

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...
NYSE:HRB
NYSE:HRBConsumer Services

Does H&R Block's (HRB) New Analyst Coverage Reframe Its Defensive Profile or Just Confirm Consensus?

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Dave (DAVE) Heads Into Earnings As Beat Expectations Meet A Near Fair Valuation

Investor attention around Dave (DAVE) has picked up ahead of the upcoming August 5 earnings report, with expectations focused on higher earnings and revenues and the possibility that results could exceed current market estimates. See our latest analysis for Dave. Despite the recent pullback, with a 1 day share price return down 6.76% and a 7 day share price return down 10.54%, Dave still shows strong momentum, with a 90 day share price return of 39.34% and a 1 year total shareholder return of...
NYSE:KKR
NYSE:KKRCapital Markets

KKR (KKR) Stock Looks Fully Priced After Its 72% Three Year Run

KKR stock is caught between two conflicting valuation signals right now, with the intrinsic value estimate from the Excess Returns model pointing to some upside while market based multiples suggest the shares are priced on the richer side after a mixed return profile. Over the past 3 years KKR has returned 72.1%, which shows the stock has already delivered strong gains over a medium term holding period. Recent deal activity in energy and infrastructure, such as the agreed DCC Energy takeover...
NYSE:TREX
NYSE:TREXBuilding

How Mixed Earnings Signals At Trex Company (TREX) Have Changed Its Investment Story

Earlier this week, analysts highlighted that Trex Company is expected to report a year-over-year earnings decline on higher revenues for the June 2026 quarter, with consensus EPS estimates revised upward over the past month but still pointing to weaker profitability. An interesting wrinkle is that Trex currently carries a top-tier Zacks Rank alongside a negative Earnings ESP, underscoring how diverging analyst signals are sharpening attention on the upcoming results. Next, we’ll examine how...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Strategic Education (STRA) Beats On Q2 Results, Is The Stock Still Fully Valued?

Strategic Education (STRA) drew fresh attention on July 29, 2026, after reporting second quarter earnings and confirming a regular quarterly cash dividend of $0.60 per share for shareholders. See our latest analysis for Strategic Education. The earnings surprise appears to have shifted sentiment toward Strategic Education, with a 7.65% 1-day share price return and 16.83% 7-day share price return, while the 1-year total shareholder return of 21.76% points to momentum building rather than...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Workday Stock And Other Founder Led Software Picks Worth Watching

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...
NYSE:OHI
NYSE:OHIHealth Care REITs

Omega Healthcare Investors (OHI) Stock May Still Trade Below Fair Value

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Is Galaxy Digital (GLXY) Quietly Recasting Its Identity Around AI Infrastructure With McGregor Campus Plans?

Galaxy Digital Inc. recently acquired approximately 500 acres in McGregor, Texas, under a development agreement to build an AI and high-performance computing data center campus, initially targeting 74 megawatts of capacity with power expected to begin flowing in 2028. This second Texas campus signals Galaxy’s push to build a multi-campus data center platform and deepen its role in the AI infrastructure supply chain. We’ll now examine how the planned 74-megawatt McGregor AI campus could...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group (MRX) Could Be 13% Undervalued After Its Recent Pullback

Marex Group (MRX) stock has drawn attention after recent trading performance, with the price closing at US$63.14. Investors are weighing this move against the company’s latest financial metrics and business mix. See our latest analysis for Marex Group. For context, Marex Group’s recent pullback, with a 1-day share price return of 1.59% lower and 7-day share price return of 4.12% lower, comes after strong momentum. This includes a 30-day share price return of 7.13%, a 90-day share price return...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart (UPST) Secures $4 Billion Castlelake Loan Funding Deal

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...